1von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum, 1995, 24:323-358.
2Barada FA, Andrews BS, Davis JS, et al. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum, 1981,24:1236-1244.
3Riemekasten G, Marell J, TrebeljahrG, et al. A novel epitope on the C-Terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest,1998, 102: 754-763.
4Ou Y, Sun D, Sharp GC, et al. Screening of SLE sera using purified recombinant Sm-D1 protein from a baculovirus expression system. Clin Immunol Immunopathol, 1997, 83: 310-317.
5Min DJ, Kim SJ, Park SH, et al. Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded-DNA antibody. Clin Exp Rheumatol, 2002,20: 13-18.
8[9]Min DJ,Kim SJ,Park SH,et al.Anti-nucleosome antibody:significance in lupus patients lacking anti-double-stranded DNA antibody.Clin Exp Rheumatol,2002,20(1):13-18.
9Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoanti bodies to nuclear antigens. Arch Pathol Lab Med, 2000, 124 (1) :71-81.
10Damoiseaux J, Boesten K, Giesen J, et al. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extract- able nuclear antigens[J]. Ann N Y Acad Sci,2005,26(3):340- 347.
